Approval granted for clinical trials of an A.I. therapist working alongside psychedelic drugs
[Claims] the biggest problem with needing human therapists after a psychedelic treatment is that it scales one to one with the number of people being treated [but] with the support of machine learning systems it can act as a live therapist.
A treatment that combines an artificial intelligence therapist with psychedelic drugs to treat depression and addiction has been approved for clinical trials. The system will allow for the automated monitoring and assessment of patients who have been prescribed psychedelic drugs to treat mental health conditions.
Original Article (Daily Mail):
Approval granted for clinical trials of an AI therapist alongside psychedelic drugs to treat depression and addiction
Artwork Fair Use: Igbofur